[HTML][HTML] 2020 Taiwan consensus statement on the management of hepatitis C: Part (II) special populations
ML Yu, PJ Chen, CY Dai, TH Hu, CF Huang… - Journal of the Formosan …, 2020 - Elsevier
Hepatitis C virus (HCV) infection is a silent killer that leads to rapid progression of liver
cirrhosis and hepatocellular carcinoma (HCC). High prevalence of HCV infection has been …
cirrhosis and hepatocellular carcinoma (HCC). High prevalence of HCV infection has been …
[HTML][HTML] 2020 Taiwan consensus statement on the management of hepatitis C: part (I) general population
ML Yu, PJ Chen, CY Dai, TH Hu, CF Huang… - Journal of the Formosan …, 2020 - Elsevier
Hepatitis C virus (HCV) infection remains a major public health issue with high prevalence in
Taiwan. Recently, the advent of direct-acting antiviral (DAA) agents, with higher efficacy …
Taiwan. Recently, the advent of direct-acting antiviral (DAA) agents, with higher efficacy …
[PDF][PDF] Australian recommendations for the management of hepatitis C virus infection: a consensus statement (September 2018)
Hepatitis C Virus Infection Consensus Statement … - 2018 - research.monash.edu
Chronic hepatitis C virus (HCV) infection is a major public health challenge for Australia,
affecting about 200 000 people who are at risk of progressive liver fibrosis leading to …
affecting about 200 000 people who are at risk of progressive liver fibrosis leading to …
EASL recommendations on treatment of hepatitis C: final update of the series☆
Hepatitis C virus (HCV) infection is a major cause of chronic liver disease, with
approximately 71 million chronically infected individuals worldwide. Clinical care for patients …
approximately 71 million chronically infected individuals worldwide. Clinical care for patients …
[HTML][HTML] EASL recommendations on treatment of hepatitis C 2015
European Association For The Study Of The Liver - Journal of hepatology, 2015 - Elsevier
Hepatitis C virus (HCV) infection is one of the main causes of chronic liver disease
worldwide [1]. The long-term impact of HCV infection is highly variable, ranging from minimal …
worldwide [1]. The long-term impact of HCV infection is highly variable, ranging from minimal …
EASL recommendations on treatment of hepatitis C 2014
European Association for The Study of The Liver - Journal of Hepatology, 2014 - Elsevier
Hepatitis C virus (HCV) infection is one of the main causes of chronic liver disease
worldwide [1]. The long-term impact of HCV infection is highly variable, ranging from minimal …
worldwide [1]. The long-term impact of HCV infection is highly variable, ranging from minimal …
Hepatitis C treatment: where are we now?
NJ Burstow, Z Mohamed, AI Gomaa… - … journal of general …, 2017 - Taylor & Francis
Chronic hepatitis C infection affects millions of people worldwide and confers significant
morbidity and mortality. Effective treatment is needed to prevent disease progression and …
morbidity and mortality. Effective treatment is needed to prevent disease progression and …
[HTML][HTML] Hepatitis C guidance 2018 update: AASLD-IDSA recommendations for testing, managing, and treating hepatitis C virus infection
AIHCVG Panel - Clinical infectious diseases: an official publication …, 2018 - ncbi.nlm.nih.gov
Recognizing the importance of timely guidance regarding the rapidly evolving field of
hepatitis C management, the American Association for the Study of Liver Diseases (AASLD) …
hepatitis C management, the American Association for the Study of Liver Diseases (AASLD) …
EASL recommendations on treatment of hepatitis C 2018
Hepatitis C virus (HCV) infection is a major cause of chronic liver disease, with
approximately 71 million chronically infected individuals worldwide. Clinical care for patients …
approximately 71 million chronically infected individuals worldwide. Clinical care for patients …
Factors associated with treatment failure of direct‐acting antivirals for chronic hepatitis C: a real‐world nationwide hepatitis C virus registry programme in Taiwan
CY Chen, CF Huang, PN Cheng, KC Tseng… - Liver …, 2021 - Wiley Online Library
Background/aims Direct‐acting antivirals (DAAs) are highly effective in treating chronic
hepatitis C virus (HCV)‐infected patients. The real‐world treatment outcome in Taiwanese …
hepatitis C virus (HCV)‐infected patients. The real‐world treatment outcome in Taiwanese …